Idera Pharmaceuticals Inc news

   Watch this stock
Showing stories 1 - 10 of about 68   

Articles published

IDRA 2.69 +0.12 (4.67%)
price chart
Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and ...
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, today reported financial and operational results for the quarter ended June 30, 2014.
Related articles »  
Trader's Buzzers - Bellatrix Exploration Ltd (NYSEMKT:BXE), Idera ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) recently reported financial and operational results for the quarter ended June 30, 2014.
Stocks Buzz - Vonage Holdings Corp. (NYSE:VG), Idera Pharmaceuticals Inc ...
Las Vegas, NV - - Aug 19, 2014� (TechSonian) - Penny Stock Earnings is comprised of a team of vetted penny stock traders who've been trading since 2008 & have developed the skills needed to trade for consistent profits through eMail and text messages.
Stocks in Focus - Idera Pharmaceuticals Inc (NASDAQ:IDRA), Millennial Media ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) recently declared financial and operational results for the quarter ended June 30, 2014.
Related articles »  
Hot Stocks-Idera Pharmaceuticals Inc (NASDAQ:IDRA),People's United ...
Idera Pharmaceuticals Inc (NASDAQ:IDRA) reported a collaboration to advance a new potential treatment approach for polymyositis and dermatomyositis known as Toll-like receptor (TLR) antagonism.
Idera Pharmaceuticals and Collaborators Publish Promising Preclinical Data ...
CAMBRIDGE, Mass., Aug 06, 2014 (BUSINESS WIRE) -- Idera Pharmaceuticals, Inc. IDRA, -2.94% a clinical-stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and rare diseases, today announced the publication ...
Related articles »  
Trader's Watch List: Idera Pharmaceuticals (NASDAQ:IDRA), Cabot Oil & Gas ...
Idera Pharmaceuticals Inc. (NASDAQ:IDRA) announced its earnings results on 12 August Tuesday. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.09) by $0.01, American Banking News reports.
Investors Are Watching: ReneSola (NYSE:SOL), Idera Pharmaceuticals ...
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for rare diseases, reported financial and operational results for the quarter ended June 30, 2014.
Idera Pharmaceuticals to Host Conference Call and Webcast to Report Second ...
5, 2014-- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a clinical stage biopharmaceutical company developing nucleic acid therapeutics for patients with cancer and orphan diseases, today announced that the Company will host a conference call and live ...
Related articles »  
News Recap � LRAD Corp (NASDAQ:LRAD), Idera Pharmaceuticals Inc ...
Manhattan, NY- August 15, 2014 - (Techsonian) - LRAD Corporation (NASDAQ:LRAD) designs, develops, and commercializes directed sound technologies and products in North and South America, Europe, the Middle East, and Asia.
Related articles »